Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Endocare Horizon urology stent clinicals to be under way in first half of 1998, CEO tells investors.

This article was originally published in The Gray Sheet

Executive Summary

ENDOCARE UROLOGY STENT CLINICALS ON HORIZON FOR FIRST HALF OF 1998, Paul Mikus, chairman and CEO, stated at an Oct. 29 session of the Oppenheimer & Co. health care conference in New York City. The Horizon stent studies will evaluate the device in preventing urine retention caused by swelling after thermal treatment of benign prostatic hyperplasia.



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts